Vincenzo Tombolini
Vincenzo Tombolini
Professore di Radioterapia
Verified email at
Cited by
Cited by
Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study
V Panebianco, F Barchetti, A Sciarra, A Ciardi, EL Indino, R Papalia, ...
Urologic Oncology: Seminars and Original Investigations 33 (1), 17. e1-17. e7, 2015
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
G Minniti, V De Sanctis, R Muni, F Filippone, A Bozzao, M Valeriani, ...
Journal of neuro-oncology 88 (1), 97-103, 2008
Fortuitously discovered liver lesions
CF Dietrich, M Sharma, RN Gibson, D Schreiber-Dietrich, C Jenssen
World Journal of Gastroenterology: WJG 19 (21), 3173, 2013
Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance
CN De Cecco, B Ganeshan, M Ciolina, M Rengo, FG Meinel, D Musio, ...
Investigative radiology 50 (4), 239-245, 2015
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
GL Gravina, C Festuccia, F Marampon, VM Popov, RG Pestell, BM Zani, ...
Molecular cancer 9 (1), 305, 2010
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
C Marchetti, F De Felice, I Palaia, G Perniola, A Musella, D Musio, L Muzii, ...
BMC women's health 14 (1), 150, 2014
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging
V Panebianco, F Barchetti, A Sciarra, D Musio, V Forte, V Gentile, ...
European radiology 23 (6), 1745-1752, 2013
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central …
S Scoccianti, SM Magrini, U Ricardi, B Detti, M Buglione, G Sotti, ...
Neurosurgery 67 (2), 446-458, 2010
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals
F Marampon, GL Gravina, A Di Rocco, P Bonfili, M Di Staso, C Fardella, ...
Molecular cancer therapeutics 10 (1), 159-168, 2011
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases
M Di Staso, L Zugaro, GL Gravina, P Bonfili, F Marampon, L Di Nicola, ...
European radiology 21 (9), 2004-2010, 2011
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
C Ciccarelli, F Vulcano, L Milazzo, GL Gravina, F Marampon, G Macioce, ...
Molecular cancer 15 (1), 16, 2016
The role of radiation therapy in bone metastases management
F De Felice, A Piccioli, D Musio, V Tombolini
Oncotarget 8 (15), 25691, 2017
Immunotherapy of ovarian cancer: the role of checkpoint inhibitors
F De Felice, C Marchetti, I Palaia, D Musio, L Muzii, V Tombolini, ...
Journal of immunology research 2015, 2015
Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis
F De Felice, C Marchetti, A Musella, I Palaia, G Perniola, D Musio, L Muzii, ...
Annals of surgical oncology 22 (9), 2876-2880, 2015
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage
G Pannone, A Santoro, A Feola, P Bufo, P Papagerakis, L Lo Muzio, ...
Current Cancer Drug Targets 14 (2), 115-127, 2014
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
F Marampon, F Megiorni, S Camero, C Crescioli, HP McDowell, R Sferra, ...
Cancer letters 397, 1-11, 2017
Comparision between transrectal ultrasonography and computed tomography with rectal inflation of gas in preoperative staging of lower rectal cancer
MF Osti, FS Padovan, C Pirolli, S Sbarbati, V Tombolini, C Meli, RM Enrici
European radiology 7 (1), 26-30, 1997
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells
GL Gravina, F Marampon, F Petini, L Biordi, D Sherris, EA Jannini, ...
Endocrine-related cancer 18 (4), 385-400, 2011
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models
GL Gravina, F Marampon, M Piccolella, M Motta, L Ventura, R Pomante, ...
Endocrinology 152 (12), 4550-4561, 2011
Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients …
CN De Cecco, M Ciolina, D Caruso, M Rengo, B Ganeshan, FG Meinel, ...
Abdominal Radiology 41 (9), 1728-1735, 2016
The system can't perform the operation now. Try again later.
Articles 1–20